p53 Immunohistochemistry Predicts 17p13(TP53) Deletion in CLL

被引：0
|
作者：
Jiang, A.
Qi, C.
Chang, H.
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
来源：
MODERN PATHOLOGY | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1223
引用
收藏
页码：269A / 269A
页数：1
相关论文
共 50 条
  • [41] p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression
    Reinhardt, Luiza Steffens
    Groen, Kira
    Xavier, Alexandre
    Avery-Kiejda, Kelly A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [42] Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia
    A Carter
    K Lin
    P D Sherrington
    M Atherton
    K Pearson
    A Douglas
    A Burford
    V Brito-Babapulle
    E Matutes
    D Catovsky
    A R Pettitt
    Leukemia, 2006, 20 : 737 - 740
  • [43] Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity
    Libe, Rossella
    Groussin, Lionel
    Tissier, Frederique
    Elie, Caroline
    Rene-Corail, Fernande
    Fratticci, Amato
    Jullian, Eric
    Beck-Peccoz, Paolo
    Bertagna, Xavier
    Gicquel, Christine
    Bertherat, Jerome
    CLINICAL CANCER RESEARCH, 2007, 13 (03) : 844 - 850
  • [44] Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia
    Carter, A
    Lin, K
    Sherrington, PD
    Atherton, M
    Pearson, K
    Douglas, A
    Burford, A
    Brito-Babapulle, V
    Matutes, E
    Catovsky, D
    Pettitt, AR
    LEUKEMIA, 2006, 20 (04) : 737 - 740
  • [45] Mutational Status of the TP53 Gene as a Predictor of Response and Survival in CLL Patients with and without 17p Deletion
    Gonzalez, David
    Martinez, Pilar
    Wade, Rachel
    Hockley, Sarah Lorna
    Brito-Babapulle, Vasantha
    Oscier, David Graham
    Matutes, Estelia
    Dearden, Claire E.
    Richards, Sue
    Catovsky, Daniel
    Morgan, Gareth J.
    BLOOD, 2008, 112 (11) : 291 - 291
  • [46] OVEREXPRESSION OF THE P53 PROTEIN AND ALLELE LOSS AT 17P13 IN OVARIAN-CARCINOMA
    ECCLES, DM
    BRETT, L
    LESSELS, A
    GRUBER, L
    LANE, D
    STEEL, CM
    LEONARD, RCF
    BRITISH JOURNAL OF CANCER, 1992, 65 (01) : 40 - 44
  • [47] LOCALIZATION OF GENE FOR HUMAN P53 TUMOR-ANTIGEN TO BAND 17P13
    ISOBE, M
    EMANUEL, BS
    GIVOL, D
    OREN, M
    CROCE, CM
    NATURE, 1986, 320 (6057) : 84 - 85
  • [48] Correlation of TP53 mutations and p53 expression in ovarian tumors
    DiCioccio, RA
    Werness, BA
    Peng, RQ
    Allen, HJ
    Piver, MS
    CANCER GENETICS AND CYTOGENETICS, 1998, 105 (02) : 93 - 102
  • [49] BSTNI/NCII POLYMORPHISM OF THE HUMAN P53 GENE (TP53)
    CHUMAKOV, PM
    JENKINS, JR
    NUCLEIC ACIDS RESEARCH, 1991, 19 (24) : 6969 - 6969
  • [50] Inhibition of TP53 Mutant Oral Cancer by Reactivating p53
    Kang, Yei-Jin
    Kim, Dae-Won
    Che, Xiangguo
    Choi, Je-Yong
    Kim, Seong-Gon
    APPLIED SCIENCES-BASEL, 2022, 12 (12):
12345